The Drugs Controller General of India has Recommended Emergency Use Authorization for Bharat Biotech’s Covaxin for Children 6 to 12 Years of Age
https://twitter.com/CNBCTV18News/status/1518877996442001408
Monitoring Board Gives Positive Recommendation On Ocugen’s Eye Disease Gene Therapy Trial
The independent Data and Safety Monitoring Board (DSMB) for Ocugen Inc’s (NASDAQ:OCGN) Phase 1/2 trial of OCU400 has recommended that…
Ocugen, Inc. To Commercialize COVAXIN In Mexico
Ocugen, Inc. (“Ocugen”) (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals and vaccines, and Bharat Biotech (BBIL), a global
@BharatBiotech Tweeted Japan Recognises India’s COVAXIN to Facilitate Travel between Both the Countries
Note: Ocugen is U.S. partner for COVAXIN
https://www.twitter.com/i/status/1512362286467682304
Read Why Did WHO Suspend UN Supply of Bharat Biotech’s Covaxin COVID-19 Vaccine
According to Reuters, the World Health Organization suspended the supply of Covaxin through UN agencies for the COVID-19…
These Were The 20 Most Searched Tickers On Benzinga In The First Quarter: Did Your Favorite Stock Make The List?
The first three months of 2022 are in the books, bringing the first quarter to a close. Investors were faced with many macro events, including rising inflation and the war in Ukraine. Benzinga was a source for many investors, providing access to news and trading tools for investors and traders alike.
Occugen Shares Move Lower; Bharat Biotech Tweets Temporary Slowing Down Of COVAXIN Production For Facility Optimization. BZ NOTE: Occugen Is Bharat Biotech’s Partner On COVAXIN
https://twitter.com/BharatBiotech/status/1509927525966761996
68 Biggest Movers From Friday
Gainers
Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday.
